HCID 67236651, compound → HCID 67245777, compound
Reaction equation
[CH3:1][C:2]1([CH3:27])[N:11]2[C:7](=[N:8][C:9]3[CH:15]=[CH:14][C:13]([C:16]([O:18]CC4C=CC=CC=4)=[O:17])=[CH:12][C:10]=32)[C:6](=[O:26])[NH:5][CH2:4][CH2:3]1>CO.[Pd]>[CH3:1][C:2]1([CH3:27])[N:11]2[C:7](=[N:8][C:9]3[CH:15]=[CH:14][C:13]([C:16]([OH:18])=[O:17])=[CH:12][C:10]=32)[C:6](=[O:26])[NH:5][CH2:4][CH2:3]1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A suspension of benzyl 5,5-dimethyl-1-oxo-2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,2-a]benzimidazole-8-carboxylate (88 mg, 0.22 mmol) in methanol (2 mL) is hydrogenated over 10% palladium on carbon (23 mg) under balloon pressure for 3 h. The catalyst is removed by filtration, and the filtrate concentrated to afford the title compound (38 mg, 63%).
Workup
- customThe catalyst is removed by filtration
- concentrationthe filtrate concentrated
Sources & evidence
- ORD record
- ord-8313919a953544e89c507463297352c0
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09073926B2
Reaction notes
Loading…